ULTRASOUND VISUALIZATION, AND ASSOCIATED SYSTEMS AND METHODS
20220032089 · 2022-02-03
Assignee
Inventors
Cpc classification
A61N2007/0052
HUMAN NECESSITIES
International classification
Abstract
Presented herein is ultrasound visualization and associated systems and methods. In one embodiment, a method for an ultrasound imaging, includes: transmitting an imaging ultrasound toward a target tissue; receiving ultrasound echoes of the imaging ultrasound using a first set of receiving beamformer parameters; composing a first two-dimensional (2D) B-mode image of the target tissue based on received ultrasound echoes of the imaging ultrasound; transmitting a therapy ultrasound toward a target tissue by a therapy transducer using a second set of transmitting beamformer parameters; receiving ultrasound echoes of the therapy ultrasound using the first set of receiving beamformer parameters; composing a second 2D B-mode image of the target tissue based on received ultrasound echoes of the therapy ultrasound; and comparing the first 2D B-mode image of the target tissue with the second 2D B-mode image of the target tissue.
Claims
1. A method for an ultrasound imaging, comprising: (i) transmitting an imaging ultrasound toward a target tissue; (ii) receiving ultrasound echoes of the imaging ultrasound using a first set of receiving beamformer parameters; (iii) composing a first two-dimensional (2D) B-mode image of the target tissue based on received ultrasound echoes of the imaging ultrasound; (iv) transmitting a therapy ultrasound toward a target tissue using a second set of transmitting beamformer parameters; (v) receiving ultrasound echoes of the therapy ultrasound using the first set of receiving beamformer parameters; (vi) composing a second 2D B-mode image of the target tissue based on received ultrasound echoes of the therapy ultrasound; and (vii) comparing the first 2D B-mode image of the target tissue with the second 2D B-mode image of the target tissue.
2. The method of claim 1, wherein comparing the first 2D B-mode image of the target tissue with the second 2D B-mode image of the target tissue comprises: displaying the first 2D B-mode image in a first color; and overlaying the second 2D B-mode image in a second color over the first 2D B-mode image.
3. The method of claim 1, wherein: the imaging ultrasound is transmitted by an imaging transducer; the ultrasound echoes of the imaging ultrasound are received by the imaging transducer; the therapy ultrasound is transmitted by a therapy transducer; and the ultrasound echoes of the therapy transducer are received by the imaging transducer.
4. The method of claim 1, wherein the therapy transducer is a phased array therapy transducer comprising a plurality of phased array elements.
5. The method of claim 4, wherein the image transducer is a phased array therapy transducer that is different from the therapy transducer.
6. The method of claim 1, wherein: the imaging ultrasound and the therapy ultrasound are transmitted and received by a same transducer which alternately executes roles of the imaging transducer and the therapy transducer.
7. The method of claim 1, further comprising: if a match between the first 2D B-mode image and the second 2D B-mode image is within a predetermined threshold match, transmitting additional therapy ultrasound toward the target tissue by a therapy transducer using the second set of transmitting beamformer parameters; and comparing the first 2D B-mode image of the target tissue with additional second 2D B-mode image of the target tissue.
8. The method of claim 7, further comprising: adjusting the second set of transmitting beamformer parameters to target another location of the target tissue; and repeating steps (i)-(vii) of claim 1.
9. The method of claim 1, further comprising: if a match between the first 2D B-mode image and the second 2D B-mode image is below a predetermined threshold match, adjusting the second set of transmitting beamformer parameters of a therapy transducer; and transmitting the therapy ultrasound toward the target tissue by the therapy transducer using the adjusted second set of transmitting beamformer parameters.
10. The method of claim 9, wherein adjusting the second set of transmitting beamformer parameters is performed by an artificial intelligence (AI) engine.
11. The method of claim 10, wherein the AI engine utilizes transducer template beam patterns as training sets to produce new element-by-element time delays that minimize differences between the second 2D B-frame and the first 2D B-frame.
12. The method of claim 10, wherein adjusting the second set of the transmitting beamformer parameters comprises performing real-time phase aberration corrections of the transmitting beamformer parameters by the AI engine.
13. The method of claim 11, further comprising: acquiring new second 2D B-frame images until a convergence to a target tolerance is achieved.
14. A computer-readable storage device storing non-volatile computer-executable instructions, which, when executed, cause an ultrasound system to: (i) transmit an imaging ultrasound toward a target tissue; (ii) receive ultrasound echoes of the imaging ultrasound using a first set of receiving beamformer parameters; (iii) compose a first two-dimensional (2D) B-mode image of the target tissue based on received ultrasound echoes of the imaging ultrasound; (iv) transmit a therapy ultrasound toward a target tissue using a second set of transmitting beamformer parameters; (v) receive ultrasound echoes of the therapy ultrasound using the first set of receiving beamformer parameters; (vi) compose a second 2D B-mode image of the target tissue based on received ultrasound echoes of the therapy ultrasound; and (vii) compare the first 2D B-mode image of the target tissue with the second 2D B-mode image of the target tissue.
15. The computer-readable storage device of claim 14, wherein the instructions further cause the ultrasound system to: determine whether a match between the first 2D B-mode image and the second 2D B-mode image is within a predetermined threshold match; if the match is within the predetermined threshold match, transmit additional therapy ultrasound toward the target tissue using the second set of transmitting beamformer parameters; and compare the first 2D B-mode image of the target tissue with additional second 2D B-mode image of the target tissue.
16. The computer-readable storage device of claim 14, wherein the instructions further cause the ultrasound system to: determine whether a match between the first 2D B-mode image and the second 2D B-mode image is within a predetermined threshold match; if the match is outside of the predetermined threshold match, adjust the second set of transmitting beamformer parameters; transmit the therapy ultrasound toward the target tissue using the adjusted second set of transmitting beamformer parameters; and compare the first 2D B-mode image of the target tissue with additional second 2D B-mode image of the target tissue.
17. The computer-readable storage device of claim 16, wherein adjusting the second set of transmitting beamformer parameters is performed by an artificial intelligence (AI) engine.
18. The computer-readable storage device of claim 17, wherein the AI engine utilizes transducer template beam patterns as training sets to produce new element-by-element time delays that minimize differences between the second 2D B-frame and the first 2D B-frame.
19. The computer-readable storage device of claim 14, wherein: the imaging ultrasound is transmitted by an imaging transducer; the ultrasound echoes of the imaging ultrasound are received by the imaging transducer; the therapy ultrasound is transmitted by a therapy transducer; and the ultrasound echoes of the therapy transducer are received by the imaging transducer.
20. The computer-readable storage device of claim 14, wherein: the imaging ultrasound and the therapy ultrasound are transmitted and received by a same transducer which alternately executes roles of the imaging transducer and the therapy transducer.
Description
DESCRIPTION OF THE DRAWINGS
[0032] The foregoing aspects and many of the attendant advantages of this inventive technology will become more readily appreciated as the same become better understood by reference to the following detailed description, when taken in conjunction with the accompanying drawings, wherein:
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
DETAILED DESCRIPTION
[0040] Example devices, methods, and systems are described herein. It should be understood the words “example,” “exemplary,” and “illustrative” are used herein to mean “serving as an example, instance, or illustration.” Any embodiment or feature described herein as being an “example,” being “exemplary,” or being “illustrative” is not necessarily to be construed as preferred or advantageous over other embodiments or features. The example embodiments described herein are not meant to be limiting. It will be readily understood aspects of the present disclosure, as generally described herein, and illustrated in the figures, can be arranged, substituted, combined, separated, and designed in a wide variety of different configurations, all of which are explicitly contemplated herein.
[0041]
[0042] In operation, the ultrasound probe 500 may be controlled by an ultrasound engine 100 that includes a controller (e.g., a computer, a smart device, etc.) with suitable software, a display 110 and commands 115 for controlling the ultrasound engine. The monitor 110 can display images of the target tissue that are obtained, for example, by an imaging transducer 300 of the ultrasound probe 100. The ultrasound probe 500 may be powered through a power cable 120.
[0043]
[0044]
[0045]
[0046]
[0047] In operation, array elements may transmit ultrasound along multiple 1D lines using the transmit beamformer. In the context of this application, the term beamformer encompasses sequential or parallel activation, phase delays, power levels, frequency of oscillation, etc., of the elements of the phased array (or the analogous parameters of a unitary ultrasound transducer). The transmitted ultrasound along 1D lines is represented by the phantom lines in
[0048] The received ultrasound echoes are acquired by a set of same or different elements of the ultrasound phased array 500 by focusing these elements at the target 1D lines using a receive beamformer. The ultrasound echoes are acquired along the dashed lines in
[0049] Once the parameters of the receive beamformer are optimized, these parameters may be used for the acquisition of the subsequent 2D ultrasound images as explained in conjunction with
[0050]
[0051] The method starts in block 705. In block 710, imaging ultrasound beams (also referred to as “imaging ultrasound” for brevity and simplicity) is emitted by an ultrasound transmitter, either a dedicated imaging transducer or a therapy transducer that also alternately fulfills the role of the imaging transducer. In block 715, the ultrasound echoes are acquired as a collection of 1D images. The ultrasound echoes are acquired using a first set of receive beamformer parameters.
[0052] In block 720, a 2D B-mode image is constructed from the acquired 1D line images. Some embodiments of such B-mode image acquisition are described in conjunction with
[0053] In block 725, the therapy transducer transmits therapy ultrasound beam. The therapy ultrasound may be transmitted using a second set of transmit beamformer parameters. In block 730, the ultrasound echoes from the therapy ultrasound are acquired using the set of receive beamformer parameters that is defined in block 715 above.
[0054] In block 735, the acquired 2D B-mode image is reconstructed as, for example, an assembly of the 1D A-mode line images. Since the parameters of the receive beamformer are at this point fixed, the reconstructed 2D B-image in block 735, which is based on the therapy ultrasound, is co-registered with the earlier-acquired 2D B-mode in block 720, which is based on the imaging ultrasound. The process may be repeated by starting from block 710 again. Blocks 710-735 may be collectively termed as a therapy beam visualization 701.
[0055] In block 740, different 2D B-mode frames may be overlaid. For example, different coloring schemes may be used for the B-modes from blocks 720 and 735. The method ends in block 745.
[0056]
[0057] Blocks 810-835 of the illustrated therapy beam visualization 801 generally correspond to blocks 710-735 shown in
[0058] In block 840, the second 2D B-mode image of the therapy beam is processed. For example, this second 2D B-mode image that is based on the ultrasound echoes of the therapy beam may be overlaid over the first 2D B-mode image obtained in blocks 815, 820 that is based on the ultrasound echoes of the imaging beam.
[0059] In block 845, a decision is made whether a match is satisfactory between the second 2D B-mode image and the first 2D B-mode image. An unsatisfactory match may indicate, as non-limiting example, an improperly targeted therapy ultrasound away from the target area or a therapy ultrasound that is properly targeted, but lacks desired pressure distribution at the target. Such unsatisfactory match is followed by adjusting therapy beam focusing delays in block 850. Adjusting of the focusing delays may include adjusting the therapy beam beamforming parameters (also referred to as adjusting the second beamforming parameters). These beamforming parameters may rely on AI to iteratively minimize differences between the second 2D B-mode image and the first 2D B-mode image or between the actual therapy beam pattern spatial pattern and the refence theoretical beam pattern for a given transducer.
[0060] As explained above, 2D B-mode frames may be fed to the AI that uses transducer template beam patterns as training sets. For a phased array therapy transducer, the AI engine may produce new element-by-element time delays that minimize differences between the actual beam patter acquired in blocks 830, 835 and a desired beam pattern. After the adjustment in block 850, the therapy ultrasound beam is transmitted in block 825, and the process repeats.
[0061] If a satisfactory match was achieved in block 845, the therapy continues in block 855 at the target location. In block 860, a decision is made whether a therapy protocol at the target location is finished. For example, the therapy protocol at the target location may be finished after a prescribed number of therapy pulses is reached or after a predetermined therapy time has elapsed. If the therapy protocol at the target location is not finished, the process proceeds to block 875 where the second 2D B-mode image from block 835 is overlaid over the first 2D B-mode image from block 820.
[0062] If the therapy protocol at the target location is finished, the process proceeds to block 865 to make a determination whether a full therapy protocol (e.g., including all target location) is finished. If the full therapy protocol is not finished yet, the therapy beam is targeted to a new location, and the process repeats from block 810. If the full therapy protocol is finished, the process stops in block 880.
[0063]
[0064] Two images are overlaid in each graph. The background image with darker shades was obtained based on the imaging ultrasound echoes (first 2D B-mode ultrasound image). The foreground image with brighter shades was obtained based on the therapy ultrasound echoes (second 2D B-mode ultrasound image). As explained above, the imaging beamformer parameters remain the same for the two images. As a result, a co-registration of the images is achieved.
[0065] The three B-mode ultrasound images of
[0066] Many embodiments of the technology described above may take the form of computer- or controller-executable instructions, including routines stored in a non-volatile memory and executed by a programmable computer or controller. Those skilled in the relevant art will appreciate that the technology can be practiced on computer/controller systems other than those shown and described above. The technology can be embodied in a special-purpose computer, controller or data processor that is specifically programmed, configured or constructed to perform one or more of the computer-executable instructions described above. Accordingly, the terms “computer” and “controller” as generally used herein refer to any data processor and can include Internet appliances and hand-held devices (including palm-top computers, wearable computers, cellular or mobile phones, multi-processor systems, processor-based or programmable consumer electronics, network computers, mini computers and the like).
[0067] From the foregoing, it will be appreciated that specific embodiments of the technology have been described herein for purposes of illustration, but that various modifications may be made without deviating from the disclosure. Moreover, while various advantages and features associated with certain embodiments have been described above in the context of those embodiments, other embodiments may also exhibit such advantages and/or features, and not all embodiments need necessarily exhibit such advantages and/or features to fall within the scope of the technology. Accordingly, the disclosure can encompass other embodiments not expressly shown or described herein.
[0068] The present application may also reference quantities and numbers. Unless specifically stated, such quantities and numbers are not to be considered restrictive, but exemplary of the possible quantities or numbers associated with the present application. Also, in this regard, the present application may use the term “plurality” to reference a quantity or number. In this regard, the term “plurality” is meant to be any number that is more than one, for example, two, three, four, five, etc. The terms “about,” “approximately,” etc., mean plus or minus 5% of the stated value.
[0069] The principles, representative embodiments, and modes of operation of the present disclosure have been described in the foregoing description. However, aspects of the present disclosure, which are intended to be protected, are not to be construed as limited to the particular embodiments disclosed. Further, the embodiments described herein are to be regarded as illustrative rather than restrictive. It will be appreciated that variations and changes may be made by others, and equivalents employed, without departing from the spirit of the present disclosure. Accordingly, it is expressly intended that all such variations, changes, and equivalents fall within the spirit and scope of the present disclosure as claimed.